Boehringer Ingelheim & Taking Cancer On

Cancer

We have a clear aspiration – to transform the lives of people with cancer by delivering meaningful advances, with the ultimate goal of curing a range of cancers. Our generational commitment to driving scientific innovation is reflected by our robust pipeline of cancer cell-directed and immuno-oncology investigational therapies, as well as the smart combination of these approaches. We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research. Simply put, for Boehringer Ingelheim, cancer care is personal, today and for generations.

Latest Article

As part of Big Little Things, we teamed up with top patient representatives from around the world to answer the most searched questions about lung cancer..

Expert insights: top online lung cancer questions answered

We teamed up with top patient representatives from around the world to answer the most searched questions about lung cancer.

Lung cancer advocates highlight the need to overcome stigma, access reliable info, and implement early diagnosis and screening.

Overcoming Stigma and Advancing Lung Cancer Advocacy

Passionate lung cancer advocates discuss the importance of overcoming stigma, accessing reliable information, and implementing early diagnosis and screening programs.

Celebrating the Big Little Things

Image of two hands holding plants with the caption "Big Little Things"

Cancer

Celebrating the Big Little Things

Discover small things that make a big impact in cancer.

The power of patient advocacy in cancer care

Illustration of a patient receiving help for a healthcare professional

Cancer

The power of patient advocacy in cancer care

Learn more about patient Larry and UICC president Jeff Dunn's commitment to patient empowerment.

Transforming Cancer Care

Illustration of two scientists looking at research

Cancer

Transforming Cancer Care

By working with a range of stakeholders, including patients, advocacy organizations, researchers, academics and more, we can make a meaningful impact in transforming the lives of people with cancer.

Collaborations

Boehringer Ingelheim is involved in long-term collaborations with world leading academics, industry, regulators and payors, as well as patients and advocacy organizations.
We take a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful areas of cancer research.